MedPath

MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A & C

MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A & C

Discontinued
DIN Number

01962892

Drug Class

Human

Market Date

Aug 13, 1998

Company
HC

aventis pasteur sa

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01962892
AIG Number0240221002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH03 MENINGOCOCCUS, A, C, BIVALENT PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution ,  Kit
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 500 MCG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 500 MCG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.